Emergency eliglustat for puget sound
Ended Awarded Last action
- Contract number
- 36C26019N0330
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $106,985
Award facts
- Contract value 100% obligated
- $106,985.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$124,810 | |
| Original award | $231,795 |
About this award
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Genzyme Corporation, a division of Sanofi Genzyme, to provide the drug eliglustat for the VA's Puget Sound healthcare network. The order was placed against Genzyme's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which has a potential value of $660 million over 5 years. This delivery order is valued at $106,985.22 and has a completion date of March 31, 2019. No set-aside designation was used for this award. Genzyme has provided various pharmaceutical products to the VA through its FSS-61-IB contract in recent years, including drugs such as Lemtrada and vandetanib.
Quick answers
Who was awarded contract 36C26019N0330?
36C26019N0330 was awarded to Genzyme Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on February 14, 2019.
How much is contract 36C26019N0330 worth?
The government has obligated $106,985 on 36C26019N0330.
Is contract 36C26019N0330 an order under another contract?
Yes. 36C26019N0330 is a delivery order under V797P2086D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26019N0330 competed?
The extent of competition for 36C26019N0330 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award